TY - JOUR
T1 - Murine ciliotoxicity and rabbit sinus mucosal healing by polyhydrated ionogen
AU - DePoortere, David
AU - Kofonow, Jennifer M.
AU - Chen, Bei
AU - Chiu, Alexander G.
AU - Cohen, Noam A.
PY - 2011/9
Y1 - 2011/9
N2 - Objectives. Determine the toxicity and efficacy of a novel antiprotease topical irrigation, polyhydrated ionogen (PHI) ± MgBr2, in improving sinonasal remucosalization following surgery. Study Design. Blinded, randomized controlled study. Setting. Academic. Subjects and Methods. Ciliary beat frequency (CBF) of murine nasal septal explants was continuously recorded before and after addition of PHI solution to asses for ciliotoxicity. To evaluate for efficacy in remucosalization, 9 New Zealand white rabbits underwent bilateral medial-wall maxillary mucosal stripping followed by placement of an indwelling irrigation catheter. In a randomized fashion one side received 3 mL of normal saline (NS) daily, whereas the contralateral side received PHI ± MgBr2. Following a 14-day therapeutic trial, remucosalization was assessed by hematoxylin and eosin staining and immunohistochemistry for β-tubulin, a marker of cilia. A semiquantitative grading of ciliated remucosalization was applied with a chi-square test to compare the saline with the PHI ± MgBr2 treatment. Results. Safety evaluation of the PHI solutions demonstrated no evidence of ciliotoxicity. Histologic semiquantitative analysis of maxillary sinus remucosalization demonstrated significantly more ciliated epithelium (>60%) in the majority of PHI (n = 4) and PHI with MgBr2 (n = 5) treatment compared with the saline treatment (<30%) (n = 9). This was confirmed with immunohistochemical staining for type IV β-tubulin a marker of respiratory cilia. Conclusions. Success of functional endoscopic sinus surgery depends on restoration of normal mucociliary clearance. Topical PHI application has previously been demonstrated to significantly increase dermal wound healing. PHI solution is not ciliotoxic, and daily topical PHI or PHI MgBr2 irrigation enhances ciliated remucosalization compared with saline.
AB - Objectives. Determine the toxicity and efficacy of a novel antiprotease topical irrigation, polyhydrated ionogen (PHI) ± MgBr2, in improving sinonasal remucosalization following surgery. Study Design. Blinded, randomized controlled study. Setting. Academic. Subjects and Methods. Ciliary beat frequency (CBF) of murine nasal septal explants was continuously recorded before and after addition of PHI solution to asses for ciliotoxicity. To evaluate for efficacy in remucosalization, 9 New Zealand white rabbits underwent bilateral medial-wall maxillary mucosal stripping followed by placement of an indwelling irrigation catheter. In a randomized fashion one side received 3 mL of normal saline (NS) daily, whereas the contralateral side received PHI ± MgBr2. Following a 14-day therapeutic trial, remucosalization was assessed by hematoxylin and eosin staining and immunohistochemistry for β-tubulin, a marker of cilia. A semiquantitative grading of ciliated remucosalization was applied with a chi-square test to compare the saline with the PHI ± MgBr2 treatment. Results. Safety evaluation of the PHI solutions demonstrated no evidence of ciliotoxicity. Histologic semiquantitative analysis of maxillary sinus remucosalization demonstrated significantly more ciliated epithelium (>60%) in the majority of PHI (n = 4) and PHI with MgBr2 (n = 5) treatment compared with the saline treatment (<30%) (n = 9). This was confirmed with immunohistochemical staining for type IV β-tubulin a marker of respiratory cilia. Conclusions. Success of functional endoscopic sinus surgery depends on restoration of normal mucociliary clearance. Topical PHI application has previously been demonstrated to significantly increase dermal wound healing. PHI solution is not ciliotoxic, and daily topical PHI or PHI MgBr2 irrigation enhances ciliated remucosalization compared with saline.
KW - Ciliotoxicity
KW - Cytokines
KW - Inflammation
KW - Matrix metalloproteases
KW - Mucosal wound healing
KW - Polyhydrated ionogen
UR - http://www.scopus.com/inward/record.url?scp=84858959499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858959499&partnerID=8YFLogxK
U2 - 10.1177/0194599811399558
DO - 10.1177/0194599811399558
M3 - Article
C2 - 21493328
AN - SCOPUS:84858959499
SN - 0194-5998
VL - 145
SP - 482
EP - 488
JO - Otolaryngology - Head and Neck Surgery
JF - Otolaryngology - Head and Neck Surgery
IS - 3
ER -